US Stock Market Move | Moderna (MRNA.US) rises more than 7% as data from two new mRNA vaccines show positive results
As of the time of writing, the stock has risen by more than 7%, closing at $27.85.
On Monday, Moderna (MRNA.US) stock price rose, rising more than 7% to $27.85 as of the time of publication. On the news front, Moderna showcased its latest data on mRNA vaccine pipeline at the IDWeek 2025 conference, including clinical results of seasonal flu vaccine mRNA-1010 and combination vaccine mRNA-1018. The data showed that both vaccines were able to induce rapid and strong immune responses in adult participants, with no significant safety concerns observed.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
